Vivanza Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 ,inter alia, to consider and approve the Un-audited Standalone ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vivanza Biosciences has informed BSE that its Board of Directors will meet on Wednesday, August 13, 2025, at the registered office in Ahmedabad. The main item on the agenda is to consider and approve the Un-audited Standalone and Consolidated Financial Results along with the Limited Review Report for the quarter ended June 30, 2025 (Q1 FY26). The notice also includes a standard 'any other business with the permission of chair' agenda item. No specific financial numbers, projections, or business decisions have been disclosed in this filing — it is purely an advance intimation under SEBI LODR Regulations 29 and 30.
This is a routine advance notice and does not itself move the stock. Investors should watch for the actual Q1 FY26 results on August 13, 2025, which will be the first set of financials under the new fiscal year and could trigger a price reaction depending on revenue and profit performance.